Johnson Pharmacare

0.86
-0.02
(-2.27%)
Market Cap
47.30 Cr
EPS
0.00
PE Ratio
-
Dividend Yield
0.00 %
52 Week High
1.44
52 Week Low
0.81
PB Ratio
0.85
Debt to Equity
0.03
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
434.15
#1 7,135.91
19.34
2,298.70
19.14
#1 347
7.00
37.90
907.65
6,395.30
18.92
609.30
#1 59.34
291
33.81
37.05
329.20
4,898.16
#1 13.16
#1 19,129.60
11.32
280
33.59
51.02
526.80
4,747.56
22.13
607.40
5.52
206
11.90
52.32
325.65
4,694.54
393.96
12,304.10
8.13
190
-1,809.40
46.58
597.70
4,241.46
129.09
874.80
54.61
-18
#1 341.27
35.19
129.97
3,704.15
-
8.00
-5.88
-10
-27.78
50.11
1,879.30
3,151.38
30.83
9,367.70
18.37
113
-8.68
47.46
283.45
1,897.79
17.07
2,468.00
16.85
66
51.71
46.93
93.03
1,185.45
258.19
25.90
1.97
4
-2,360.00
37.41
Growth Rate
Revenue Growth
-100.00 %
Net Income Growth
-84.62 %
Cash Flow Change
87.50 %
ROE
-84.58 %
ROCE
-85.40 %
EBITDA Margin (Avg.)
-100.00 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
0
0
0
0
1
0
1
3
3
0
0
Expenses
0
0
0
0
1
0
1
3
4
0
0
EBITDA
0
-0
-0
-0
0
-0
0
0
-1
-0
0
Operating Profit %
0 %
0 %
0 %
0 %
-1 %
0 %
0 %
4 %
-53 %
0 %
0 %
Depreciation
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
-0
-0
-0
-0
0
-0
0
0
-1
-0
0
Tax
0
0
0
0
0
0
0
0
0
0
0
Net Profit
-0
-0
-0
-0
0
-0
0
0
-1
-0
0
EPS in ₹
-0.01
-0.03
-0.02
-0.01
0.00
-0.02
0.00
0.00
-0.02
0.00
0.00

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
60
59
59
60
60
59
60
60
60
60
Fixed Assets
0
0
0
0
0
0
0
0
0
0
Current Assets
4
22
4
4
5
5
6
1
0
0
Capital Work in Progress
0
0
0
0
0
0
0
0
0
0
Investments
0
8
54
54
53
52
52
54
46
46
Other Assets
60
51
5
6
7
7
7
6
14
14
Total Liabilities
60
59
59
60
60
59
60
60
60
60
Current Liabilities
0
0
0
0
0
0
1
1
1
1
Non Current Liabilities
1
1
1
2
2
1
1
1
2
2
Total Equity
59
58
58
58
58
58
58
58
57
57
Reserve & Surplus
9
8
8
8
8
8
8
3
2
2
Share Capital
50
50
50
50
50
50
50
55
55
55

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
21
0
0
0
0
0
-0
-0
0
0
Investing Activities
10
11
-11
-0
1
1
0
-5
-1
0
Operating Activities
8
-11
11
-1
-1
0
-0
5
-0
-0
Financing Activities
2
0
0
1
0
-1
0
-0
1
0

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Jan 2021
Mar 2022
Apr 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
9.66 %
9.50 %
14.45 %
20.70 %
20.70 %
75.59 %
75.26 %
75.88 %
82.77 %
85.57 %
85.56 %
85.56 %
85.56 %
85.56 %
85.56 %
85.56 %
85.56 %
85.56 %
85.56 %
Others
90.34 %
90.50 %
85.55 %
79.30 %
79.30 %
24.41 %
24.74 %
24.12 %
17.23 %
14.43 %
14.44 %
14.44 %
14.44 %
14.44 %
14.44 %
14.44 %
14.44 %
14.44 %
14.44 %
No of Share Holders
0
549
781
981
7,702
7,702
88,456
93,638
1,05,508
1,12,405
1,16,977
1,16,971
1,16,965
1,16,971
1,16,926
1,16,901
1,17,397
1,17,101
1,17,105

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
31 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
31 Jan 2025 1.05 1.03
13 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2024 1.12 1.16
28 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
28 Sept 2024 1.16 1.14
08 Apr 2022 BONUS Bonus
1:10
07 Apr 2022 1.13 1.48
23 Aug 2021 CHANGE OF NAME Change Of Name
NA
23 Aug 2021 0.25 0.25

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2025
Closure of Trading WindowMar 21, 2025
Integrated Filing (Financial)Jan 31, 2025
Pursuant To Second Proviso To Regulation 30(6) And Regulation 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 We Hereby Inform You That The Board Of Directors Of TheJan 31, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 31St January 2025.Jan 31, 2025
Announcement under Regulation 30 (LODR)-Change in Registered Office AddressJan 22, 2025
Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations 2015 - Intimation Of Board Meeting.Jan 21, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 11, 2025
Closure of Trading WindowDec 27, 2024
Un-Audited Financial Result Quarter And Half Year Ended On 30Th September 2024 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations, 2015.Nov 13, 2024
Board Meeting Outcome for Un-Audited Financial Result Quarter And Half Year Ended On 30Th September 2024 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations, 2015.Nov 13, 2024
Updation In The Website Of The CompanyOct 23, 2024
Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting.Oct 15, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 07, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 28, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 28, 2024
Closure of Trading WindowSep 26, 2024
Reg. 34 (1) Annual Report.Sep 05, 2024
Intimation Of Book Closure Pursuant To Regulation 42 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.Sep 05, 2024
Submission Of Notice Of Annual General Meeting Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015Sep 05, 2024
Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board MeetingAug 01, 2024
Board Meeting Outcome for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board MeetingAug 01, 2024
Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting.Jul 25, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 05, 2024
Closure of Trading WindowJun 28, 2024
Board Meeting Outcome for Audited Financial Results Held On 25Th May, 2024May 25, 2024
Audited Financial Results Of The Company For The Quarter And Year Ended On 31St March 2024.May 25, 2024
Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting.May 16, 2024
Submission Of Certificate By PCS Under Regulation 40(9) Of The SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015.Apr 30, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Apr 27, 2024
Compliance Certificate Pursuant To Regulation 7(3) Of The SEDIListing Obligations And Disclosure Requirements) Reguiations,2015 For The Period From April 1,2023 To March 31, 2024Apr 24, 2024
Closure of Trading WindowMar 29, 2024
Un-Audited Financial Result Quarter Ended On 31St December 2023 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations, 2015.Feb 13, 2024
Regulations 30, 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Jan 22, 2024
Board Meeting Outcome for Un-Audited Financial Result Quarter Ended On 31St December 2023 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations, 2015.Jan 22, 2024
Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting.Jan 16, 2024
Clarification sought from Johnson Pharmacare LtdJan 08, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jan 08, 2024
Closure of Trading WindowDec 27, 2023
Un-Audited Financial Result Quarter And Half Year Ended On 30Th September 2023 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations, 2015.Nov 01, 2023
Board Meeting Outcome for Un-Audited Financial Result Quarter And Half Year Ended On 30Th September 2023 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations, 2015.<BR> <BR>Nov 01, 2023
Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting.Oct 26, 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 05, 2023
Closure of Trading WindowSep 30, 2023
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 29, 2023
Updation In The Website Of The Company.Sep 28, 2023
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 28, 2023
Reg. 34 (1) Annual Report.Sep 06, 2023
Intimation Of Book Closure Pursuant To Regulation 42 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.Sep 06, 2023
Submission Of Notice Of Annual General Meeting Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015Sep 06, 2023

Technical Indicators

RSI(14)
Neutral
27.55
ATR(14)
Volatile
0.04
STOCH(9,6)
Neutral
24.20
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
-0.01
ADX(14)
Weak Trend
22.96
UO(9)
Bearish
53.73
ROC(12)
Downtrend And Accelerating
-12.24
WillR(14)
Neutral
-73.68